nodes	percent_of_prediction	percent_of_DWPC	metapath
Granisetron—CYP1A1—chronic obstructive pulmonary disease	0.493	1	CbGaD
Granisetron—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0513	0.17	CbGbCtD
Granisetron—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0513	0.17	CbGbCtD
Granisetron—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0457	0.152	CbGbCtD
Granisetron—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.043	0.143	CbGbCtD
Granisetron—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0291	0.0966	CbGbCtD
Granisetron—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0277	0.0921	CbGbCtD
Granisetron—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0247	0.0821	CbGbCtD
Granisetron—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0145	0.0482	CbGbCtD
Granisetron—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0137	0.0455	CbGbCtD
Granisetron—CYP1A1—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00248	0.0608	CbGpPWpGaD
Granisetron—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00169	0.0414	CbGpPWpGaD
Granisetron—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00149	0.0366	CbGpPWpGaD
Granisetron—HTR3A—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00145	0.0355	CbGpPWpGaD
Granisetron—HTR3A—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00129	0.0316	CbGpPWpGaD
Granisetron—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00122	0.0299	CbGpPWpGaD
Granisetron—CYP1A1—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.00113	0.0278	CbGpPWpGaD
Granisetron—CYP1A1—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.00103	0.0253	CbGpPWpGaD
Granisetron—Atropine—CYP1A2—chronic obstructive pulmonary disease	0.000962	1	CrCbGaD
Granisetron—CYP1A1—Estrogen Receptor Pathway—CYP1A2—chronic obstructive pulmonary disease	0.000768	0.0188	CbGpPWpGaD
Granisetron—CYP1A1—Oxidative Stress—SOD3—chronic obstructive pulmonary disease	0.000718	0.0176	CbGpPWpGaD
Granisetron—CYP1A1—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000651	0.0159	CbGpPWpGaD
Granisetron—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00062	0.0152	CbGpPWpGaD
Granisetron—CYP3A5—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.0006	0.0147	CbGpPWpGaD
Granisetron—CYP1A1—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000592	0.0145	CbGpPWpGaD
Granisetron—CYP3A5—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000576	0.0141	CbGpPWpGaD
Granisetron—CYP3A5—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000554	0.0136	CbGpPWpGaD
Granisetron—CYP1A1—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000544	0.0133	CbGpPWpGaD
Granisetron—CYP1A1—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000524	0.0128	CbGpPWpGaD
Granisetron—HTR3A—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000504	0.0123	CbGpPWpGaD
Granisetron—CYP2D6—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.00049	0.012	CbGpPWpGaD
Granisetron—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000476	0.0117	CbGpPWpGaD
Granisetron—CYP1A1—Oxidative Stress—GCLC—chronic obstructive pulmonary disease	0.000468	0.0115	CbGpPWpGaD
Granisetron—CYP1A1—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000454	0.0111	CbGpPWpGaD
Granisetron—HTR3A—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000449	0.011	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000436	0.0107	CbGpPWpGaD
Granisetron—CYP3A5—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000419	0.0103	CbGpPWpGaD
Granisetron—CYP2D6—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.00041	0.01	CbGpPWpGaD
Granisetron—CYP1A1—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000404	0.00991	CbGpPWpGaD
Granisetron—CYP3A5—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000403	0.00987	CbGpPWpGaD
Granisetron—CYP2D6—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000394	0.00965	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000393	0.00964	CbGpPWpGaD
Granisetron—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000369	0.00903	CbGpPWpGaD
Granisetron—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000356	0.00872	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000333	0.00815	CbGpPWpGaD
Granisetron—CYP1A1—Oxidative Stress—HMOX1—chronic obstructive pulmonary disease	0.000324	0.00793	CbGpPWpGaD
Granisetron—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.00032	0.00785	CbGpPWpGaD
Granisetron—CYP1A1—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000314	0.00768	CbGpPWpGaD
Granisetron—CYP2D6—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000304	0.00746	CbGpPWpGaD
Granisetron—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000302	0.00184	CcSEcCtD
Granisetron—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000302	0.00184	CcSEcCtD
Granisetron—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000302	0.00184	CcSEcCtD
Granisetron—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000302	0.00184	CcSEcCtD
Granisetron—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000302	0.00184	CcSEcCtD
Granisetron—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000302	0.00184	CcSEcCtD
Granisetron—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000301	0.00183	CcSEcCtD
Granisetron—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000301	0.00183	CcSEcCtD
Granisetron—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000301	0.00183	CcSEcCtD
Granisetron—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.0003	0.00183	CcSEcCtD
Granisetron—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.0003	0.00183	CcSEcCtD
Granisetron—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.0003	0.00183	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.0003	0.00183	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.0003	0.00183	CcSEcCtD
Granisetron—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000298	0.00182	CcSEcCtD
Granisetron—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000298	0.00182	CcSEcCtD
Granisetron—CYP2D6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000298	0.00729	CbGpPWpGaD
Granisetron—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000296	0.0018	CcSEcCtD
Granisetron—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000296	0.0018	CcSEcCtD
Granisetron—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000295	0.0018	CcSEcCtD
Granisetron—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000295	0.0018	CcSEcCtD
Granisetron—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000294	0.00179	CcSEcCtD
Granisetron—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000294	0.00179	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000293	0.00179	CcSEcCtD
Granisetron—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000293	0.00179	CcSEcCtD
Granisetron—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000292	0.00178	CcSEcCtD
Granisetron—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000291	0.00714	CbGpPWpGaD
Granisetron—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000289	0.00176	CcSEcCtD
Granisetron—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000289	0.00176	CcSEcCtD
Granisetron—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000289	0.00176	CcSEcCtD
Granisetron—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000289	0.00176	CcSEcCtD
Granisetron—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.00176	CcSEcCtD
Granisetron—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000287	0.00175	CcSEcCtD
Granisetron—Infection—Formoterol—chronic obstructive pulmonary disease	0.000287	0.00175	CcSEcCtD
Granisetron—CYP2D6—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000286	0.00701	CbGpPWpGaD
Granisetron—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000285	0.00174	CcSEcCtD
Granisetron—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000285	0.00174	CcSEcCtD
Granisetron—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000285	0.00174	CcSEcCtD
Granisetron—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000284	0.00173	CcSEcCtD
Granisetron—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000284	0.00173	CcSEcCtD
Granisetron—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000284	0.00173	CcSEcCtD
Granisetron—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000283	0.00173	CcSEcCtD
Granisetron—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000283	0.00173	CcSEcCtD
Granisetron—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000283	0.00173	CcSEcCtD
Granisetron—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000282	0.00172	CcSEcCtD
Granisetron—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000282	0.00172	CcSEcCtD
Granisetron—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000281	0.00172	CcSEcCtD
Granisetron—Infection—Montelukast—chronic obstructive pulmonary disease	0.000281	0.00172	CcSEcCtD
Granisetron—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000281	0.00171	CcSEcCtD
Granisetron—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000281	0.00171	CcSEcCtD
Granisetron—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00028	0.00171	CcSEcCtD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—CYP1A2—chronic obstructive pulmonary disease	0.00028	0.00685	CbGpPWpGaD
Granisetron—CYP1A1—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00028	0.00685	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CYP1A2—chronic obstructive pulmonary disease	0.00028	0.00685	CbGpPWpGaD
Granisetron—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000279	0.00684	CbGpPWpGaD
Granisetron—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000279	0.0017	CcSEcCtD
Granisetron—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000278	0.00169	CcSEcCtD
Granisetron—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000277	0.00169	CcSEcCtD
Granisetron—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000277	0.00169	CcSEcCtD
Granisetron—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000275	0.00168	CcSEcCtD
Granisetron—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000273	0.00166	CcSEcCtD
Granisetron—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000273	0.00166	CcSEcCtD
Granisetron—HTR3A—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000273	0.00668	CbGpPWpGaD
Granisetron—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000271	0.00165	CcSEcCtD
Granisetron—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00027	0.00165	CcSEcCtD
Granisetron—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00027	0.00165	CcSEcCtD
Granisetron—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000269	0.00164	CcSEcCtD
Granisetron—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000269	0.00164	CcSEcCtD
Granisetron—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000268	0.00656	CbGpPWpGaD
Granisetron—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000268	0.00163	CcSEcCtD
Granisetron—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000267	0.00162	CcSEcCtD
Granisetron—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000265	0.00162	CcSEcCtD
Granisetron—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000264	0.00161	CcSEcCtD
Granisetron—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000264	0.00161	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000264	0.00161	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000264	0.00161	CcSEcCtD
Granisetron—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000262	0.00159	CcSEcCtD
Granisetron—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000262	0.00159	CcSEcCtD
Granisetron—CYP1A1—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000262	0.00641	CbGpPWpGaD
Granisetron—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00026	0.00158	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000258	0.00157	CcSEcCtD
Granisetron—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000258	0.00157	CcSEcCtD
Granisetron—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000258	0.00157	CcSEcCtD
Granisetron—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000258	0.00631	CbGpPWpGaD
Granisetron—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000257	0.00157	CcSEcCtD
Granisetron—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000257	0.00157	CcSEcCtD
Granisetron—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000256	0.00156	CcSEcCtD
Granisetron—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000255	0.00156	CcSEcCtD
Granisetron—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000255	0.00155	CcSEcCtD
Granisetron—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000255	0.00155	CcSEcCtD
Granisetron—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000254	0.00155	CcSEcCtD
Granisetron—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000254	0.00155	CcSEcCtD
Granisetron—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000252	0.00153	CcSEcCtD
Granisetron—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000251	0.00153	CcSEcCtD
Granisetron—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00025	0.00152	CcSEcCtD
Granisetron—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00025	0.00152	CcSEcCtD
Granisetron—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000249	0.00152	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000249	0.00152	CcSEcCtD
Granisetron—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000247	0.00151	CcSEcCtD
Granisetron—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000247	0.00151	CcSEcCtD
Granisetron—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000247	0.00151	CcSEcCtD
Granisetron—Pain—Formoterol—chronic obstructive pulmonary disease	0.000247	0.00151	CcSEcCtD
Granisetron—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000247	0.00151	CcSEcCtD
Granisetron—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000245	0.00149	CcSEcCtD
Granisetron—CYP3A5—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000245	0.006	CbGpPWpGaD
Granisetron—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000245	0.00149	CcSEcCtD
Granisetron—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000243	0.00148	CcSEcCtD
Granisetron—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000243	0.00148	CcSEcCtD
Granisetron—Pain—Montelukast—chronic obstructive pulmonary disease	0.000242	0.00148	CcSEcCtD
Granisetron—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000242	0.00147	CcSEcCtD
Granisetron—HTR3A—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000241	0.00591	CbGpPWpGaD
Granisetron—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00024	0.00147	CcSEcCtD
Granisetron—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00024	0.00146	CcSEcCtD
Granisetron—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000239	0.00146	CcSEcCtD
Granisetron—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000239	0.00586	CbGpPWpGaD
Granisetron—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000238	0.00145	CcSEcCtD
Granisetron—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000238	0.00145	CcSEcCtD
Granisetron—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000238	0.00145	CcSEcCtD
Granisetron—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000237	0.00145	CcSEcCtD
Granisetron—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000237	0.00144	CcSEcCtD
Granisetron—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000237	0.00144	CcSEcCtD
Granisetron—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000237	0.00144	CcSEcCtD
Granisetron—CYP3A5—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000236	0.00579	CbGpPWpGaD
Granisetron—CYP2D6—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000236	0.00578	CbGpPWpGaD
Granisetron—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000236	0.00144	CcSEcCtD
Granisetron—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000234	0.00142	CcSEcCtD
Granisetron—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000234	0.00142	CcSEcCtD
Granisetron—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000233	0.0057	CbGpPWpGaD
Granisetron—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000232	0.00141	CcSEcCtD
Granisetron—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000232	0.00141	CcSEcCtD
Granisetron—CYP1A1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000231	0.00566	CbGpPWpGaD
Granisetron—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00023	0.0014	CcSEcCtD
Granisetron—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00023	0.0014	CcSEcCtD
Granisetron—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000229	0.00139	CcSEcCtD
Granisetron—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000229	0.00139	CcSEcCtD
Granisetron—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000229	0.00139	CcSEcCtD
Granisetron—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000229	0.00139	CcSEcCtD
Granisetron—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000228	0.00139	CcSEcCtD
Granisetron—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000226	0.00554	CbGpPWpGaD
Granisetron—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000226	0.00138	CcSEcCtD
Granisetron—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000226	0.00138	CcSEcCtD
Granisetron—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000226	0.00138	CcSEcCtD
Granisetron—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000225	0.00137	CcSEcCtD
Granisetron—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000225	0.00137	CcSEcCtD
Granisetron—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000225	0.00137	CcSEcCtD
Granisetron—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000224	0.00137	CcSEcCtD
Granisetron—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000224	0.00136	CcSEcCtD
Granisetron—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000224	0.00136	CcSEcCtD
Granisetron—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000223	0.00547	CbGpPWpGaD
Granisetron—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.00136	CcSEcCtD
Granisetron—CYP1A1—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000223	0.00547	CbGpPWpGaD
Granisetron—CYP2D6—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000221	0.00542	CbGpPWpGaD
Granisetron—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000217	0.00132	CcSEcCtD
Granisetron—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000216	0.00132	CcSEcCtD
Granisetron—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000216	0.00132	CcSEcCtD
Granisetron—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000213	0.0013	CcSEcCtD
Granisetron—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000213	0.0013	CcSEcCtD
Granisetron—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000213	0.0013	CcSEcCtD
Granisetron—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000212	0.00129	CcSEcCtD
Granisetron—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000212	0.00519	CbGpPWpGaD
Granisetron—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000211	0.00128	CcSEcCtD
Granisetron—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000209	0.00127	CcSEcCtD
Granisetron—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000208	0.00126	CcSEcCtD
Granisetron—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000208	0.00126	CcSEcCtD
Granisetron—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000205	0.00125	CcSEcCtD
Granisetron—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000205	0.00125	CcSEcCtD
Granisetron—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000204	0.00124	CcSEcCtD
Granisetron—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000203	0.00124	CcSEcCtD
Granisetron—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000201	0.00123	CcSEcCtD
Granisetron—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000201	0.00123	CcSEcCtD
Granisetron—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.0002	0.00122	CcSEcCtD
Granisetron—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000198	0.00121	CcSEcCtD
Granisetron—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000198	0.00121	CcSEcCtD
Granisetron—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000197	0.0012	CcSEcCtD
Granisetron—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000196	0.00119	CcSEcCtD
Granisetron—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000195	0.00477	CbGpPWpGaD
Granisetron—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000194	0.00475	CbGpPWpGaD
Granisetron—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000194	0.00118	CcSEcCtD
Granisetron—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000193	0.00118	CcSEcCtD
Granisetron—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000191	0.00117	CcSEcCtD
Granisetron—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000191	0.00117	CcSEcCtD
Granisetron—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000187	0.00114	CcSEcCtD
Granisetron—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000187	0.00459	CbGpPWpGaD
Granisetron—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000187	0.00114	CcSEcCtD
Granisetron—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000184	0.00112	CcSEcCtD
Granisetron—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000184	0.00112	CcSEcCtD
Granisetron—CYP1A1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000183	0.00449	CbGpPWpGaD
Granisetron—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000182	0.00111	CcSEcCtD
Granisetron—Rash—Formoterol—chronic obstructive pulmonary disease	0.000182	0.00111	CcSEcCtD
Granisetron—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000182	0.00111	CcSEcCtD
Granisetron—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000182	0.00111	CcSEcCtD
Granisetron—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000181	0.0011	CcSEcCtD
Granisetron—Headache—Formoterol—chronic obstructive pulmonary disease	0.000181	0.0011	CcSEcCtD
Granisetron—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000181	0.0011	CcSEcCtD
Granisetron—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00018	0.0011	CcSEcCtD
Granisetron—Rash—Montelukast—chronic obstructive pulmonary disease	0.000179	0.00109	CcSEcCtD
Granisetron—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000178	0.00109	CcSEcCtD
Granisetron—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000178	0.00109	CcSEcCtD
Granisetron—Headache—Montelukast—chronic obstructive pulmonary disease	0.000177	0.00108	CcSEcCtD
Granisetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000175	0.00429	CbGpPWpGaD
Granisetron—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000174	0.00426	CbGpPWpGaD
Granisetron—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000174	0.00426	CbGpPWpGaD
Granisetron—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.00106	CcSEcCtD
Granisetron—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000173	0.00105	CcSEcCtD
Granisetron—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000172	0.00105	CcSEcCtD
Granisetron—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000172	0.00105	CcSEcCtD
Granisetron—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000172	0.00105	CcSEcCtD
Granisetron—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000172	0.00105	CcSEcCtD
Granisetron—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000172	0.00105	CcSEcCtD
Granisetron—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000172	0.00105	CcSEcCtD
Granisetron—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000172	0.0042	CbGpPWpGaD
Granisetron—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000171	0.00104	CcSEcCtD
Granisetron—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00017	0.00417	CbGpPWpGaD
Granisetron—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000169	0.00103	CcSEcCtD
Granisetron—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000168	0.00103	CcSEcCtD
Granisetron—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000168	0.00411	CbGpPWpGaD
Granisetron—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.00101	CcSEcCtD
Granisetron—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000163	0.000994	CcSEcCtD
Granisetron—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.000989	CcSEcCtD
Granisetron—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000161	0.000984	CcSEcCtD
Granisetron—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000157	0.000959	CcSEcCtD
Granisetron—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000157	0.000955	CcSEcCtD
Granisetron—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000157	0.000955	CcSEcCtD
Granisetron—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000154	0.000939	CcSEcCtD
Granisetron—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000153	0.000932	CcSEcCtD
Granisetron—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000151	0.000923	CcSEcCtD
Granisetron—CYP1A1—PPARA activates gene expression—CTGF—chronic obstructive pulmonary disease	0.000151	0.0037	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000149	0.00365	CbGpPWpGaD
Granisetron—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000149	0.000906	CcSEcCtD
Granisetron—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—chronic obstructive pulmonary disease	0.000148	0.00362	CbGpPWpGaD
Granisetron—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000145	0.000886	CcSEcCtD
Granisetron—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000872	CcSEcCtD
Granisetron—HTR3A—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000143	0.0035	CbGpPWpGaD
Granisetron—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000142	0.000863	CcSEcCtD
Granisetron—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000142	0.000863	CcSEcCtD
Granisetron—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000141	0.00345	CbGpPWpGaD
Granisetron—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000141	0.000857	CcSEcCtD
Granisetron—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000139	0.00085	CcSEcCtD
Granisetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000138	0.00338	CbGpPWpGaD
Granisetron—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000138	0.00337	CbGpPWpGaD
Granisetron—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000134	0.000816	CcSEcCtD
Granisetron—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000789	CcSEcCtD
Granisetron—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000129	0.000787	CcSEcCtD
Granisetron—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000786	CcSEcCtD
Granisetron—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000128	0.000781	CcSEcCtD
Granisetron—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000767	CcSEcCtD
Granisetron—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000764	CcSEcCtD
Granisetron—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000762	CcSEcCtD
Granisetron—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000124	0.000758	CcSEcCtD
Granisetron—CYP3A5—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000124	0.00304	CbGpPWpGaD
Granisetron—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000124	0.00303	CbGpPWpGaD
Granisetron—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000123	0.000747	CcSEcCtD
Granisetron—CYP3A5—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000123	0.003	CbGpPWpGaD
Granisetron—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000122	0.00299	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000121	0.00297	CbGpPWpGaD
Granisetron—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000734	CcSEcCtD
Granisetron—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000724	CcSEcCtD
Granisetron—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000721	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000719	CcSEcCtD
Granisetron—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000715	CcSEcCtD
Granisetron—CYP1A1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000117	0.00287	CbGpPWpGaD
Granisetron—CYP1A1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000116	0.00284	CbGpPWpGaD
Granisetron—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.000703	CcSEcCtD
Granisetron—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000694	CcSEcCtD
Granisetron—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000694	CcSEcCtD
Granisetron—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000114	0.00279	CbGpPWpGaD
Granisetron—Infection—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000689	CcSEcCtD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	0.000112	0.00275	CbGpPWpGaD
Granisetron—Shock—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000682	CcSEcCtD
Granisetron—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000112	0.00068	CcSEcCtD
Granisetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000111	0.00273	CbGpPWpGaD
Granisetron—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000677	CcSEcCtD
Granisetron—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000674	CcSEcCtD
Granisetron—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000671	CcSEcCtD
Granisetron—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.00011	0.00269	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.000104	0.00254	CbGpPWpGaD
Granisetron—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000632	CcSEcCtD
Granisetron—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.000631	CcSEcCtD
Granisetron—CYP3A5—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000103	0.00252	CbGpPWpGaD
Granisetron—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000627	CcSEcCtD
Granisetron—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000623	CcSEcCtD
Granisetron—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	0.000102	0.0025	CbGpPWpGaD
Granisetron—CYP3A5—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000102	0.00249	CbGpPWpGaD
Granisetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.0001	0.00246	CbGpPWpGaD
Granisetron—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.0001	0.000611	CcSEcCtD
Granisetron—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.0001	0.00245	CbGpPWpGaD
Granisetron—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	9.89e-05	0.000603	CcSEcCtD
Granisetron—HTR3A—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	9.88e-05	0.00242	CbGpPWpGaD
Granisetron—Rash—Prednisolone—chronic obstructive pulmonary disease	9.88e-05	0.000602	CcSEcCtD
Granisetron—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	9.87e-05	0.000601	CcSEcCtD
Granisetron—Headache—Prednisolone—chronic obstructive pulmonary disease	9.81e-05	0.000598	CcSEcCtD
Granisetron—CYP1A1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.73e-05	0.00239	CbGpPWpGaD
Granisetron—Constipation—Prednisone—chronic obstructive pulmonary disease	9.73e-05	0.000593	CcSEcCtD
Granisetron—CYP1A1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.6e-05	0.00235	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	9.52e-05	0.00233	CbGpPWpGaD
Granisetron—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	9.38e-05	0.000572	CcSEcCtD
Granisetron—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	9.31e-05	0.000567	CcSEcCtD
Granisetron—Nausea—Prednisolone—chronic obstructive pulmonary disease	9.3e-05	0.000567	CcSEcCtD
Granisetron—Urticaria—Prednisone—chronic obstructive pulmonary disease	9.04e-05	0.000551	CcSEcCtD
Granisetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	9.02e-05	0.00221	CbGpPWpGaD
Granisetron—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	9e-05	0.000548	CcSEcCtD
Granisetron—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	9e-05	0.000548	CcSEcCtD
Granisetron—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.82e-05	0.00216	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	8.73e-05	0.00214	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.71e-05	0.00214	CbGpPWpGaD
Granisetron—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.59e-05	0.00211	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	8.56e-05	0.0021	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	8.56e-05	0.0021	CbGpPWpGaD
Granisetron—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.48e-05	0.00208	CbGpPWpGaD
Granisetron—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	8.39e-05	0.000511	CcSEcCtD
Granisetron—HTR3A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	8.37e-05	0.00205	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	8.23e-05	0.00202	CbGpPWpGaD
Granisetron—Asthenia—Prednisone—chronic obstructive pulmonary disease	8.17e-05	0.000498	CcSEcCtD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	8.16e-05	0.002	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	8.16e-05	0.002	CbGpPWpGaD
Granisetron—CYP1A1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.12e-05	0.00199	CbGpPWpGaD
Granisetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.08e-05	0.00198	CbGpPWpGaD
Granisetron—Pruritus—Prednisone—chronic obstructive pulmonary disease	8.05e-05	0.000491	CcSEcCtD
Granisetron—CYP1A1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.01e-05	0.00196	CbGpPWpGaD
Granisetron—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	7.98e-05	0.00195	CbGpPWpGaD
Granisetron—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.9e-05	0.00193	CbGpPWpGaD
Granisetron—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.79e-05	0.00191	CbGpPWpGaD
Granisetron—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	7.79e-05	0.000475	CcSEcCtD
Granisetron—Dizziness—Prednisone—chronic obstructive pulmonary disease	7.53e-05	0.000459	CcSEcCtD
Granisetron—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.49e-05	0.00183	CbGpPWpGaD
Granisetron—CYP1A1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.46e-05	0.00183	CbGpPWpGaD
Granisetron—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.38e-05	0.00181	CbGpPWpGaD
Granisetron—CYP1A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.36e-05	0.0018	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.33e-05	0.0018	CbGpPWpGaD
Granisetron—Vomiting—Prednisone—chronic obstructive pulmonary disease	7.24e-05	0.000441	CcSEcCtD
Granisetron—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.23e-05	0.00177	CbGpPWpGaD
Granisetron—Rash—Prednisone—chronic obstructive pulmonary disease	7.18e-05	0.000437	CcSEcCtD
Granisetron—Dermatitis—Prednisone—chronic obstructive pulmonary disease	7.17e-05	0.000437	CcSEcCtD
Granisetron—Headache—Prednisone—chronic obstructive pulmonary disease	7.13e-05	0.000435	CcSEcCtD
Granisetron—Nausea—Prednisone—chronic obstructive pulmonary disease	6.76e-05	0.000412	CcSEcCtD
Granisetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.55e-05	0.00161	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.11e-05	0.0015	CbGpPWpGaD
Granisetron—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.03e-05	0.00148	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	6.02e-05	0.00148	CbGpPWpGaD
Granisetron—HTR3A—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.93e-05	0.00145	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.76e-05	0.00141	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.7e-05	0.0014	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—APIP—chronic obstructive pulmonary disease	5.69e-05	0.00139	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.62e-05	0.00138	CbGpPWpGaD
Granisetron—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.54e-05	0.00136	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.32e-05	0.0013	CbGpPWpGaD
Granisetron—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.25e-05	0.00129	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.79e-05	0.00117	CbGpPWpGaD
Granisetron—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.72e-05	0.00116	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	4.28e-05	0.00105	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.06e-05	0.000994	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.99e-05	0.000979	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.99e-05	0.000978	CbGpPWpGaD
Granisetron—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.94e-05	0.000965	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	3.88e-05	0.000951	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.77e-05	0.000924	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.74e-05	0.000916	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.67e-05	0.0009	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GC—chronic obstructive pulmonary disease	3.67e-05	0.000898	CbGpPWpGaD
Granisetron—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.62e-05	0.000887	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.61e-05	0.000884	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.48e-05	0.000853	CbGpPWpGaD
Granisetron—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.43e-05	0.000841	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.41e-05	0.000835	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.84e-05	0.000695	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.8e-05	0.000686	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	2.76e-05	0.000676	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.57e-05	0.000629	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.12e-05	0.000519	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	2.1e-05	0.000513	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2e-05	0.000491	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.98e-05	0.000485	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	1.91e-05	0.000469	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.85e-05	0.000454	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.85e-05	0.000452	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.81e-05	0.000443	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.8e-05	0.000442	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.76e-05	0.000432	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.68e-05	0.000411	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.66e-05	0.000408	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.51e-05	0.000369	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.49e-05	0.000365	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.47e-05	0.00036	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.45e-05	0.000355	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.39e-05	0.00034	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.37e-05	0.000335	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.36e-05	0.000333	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.35e-05	0.000331	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.28e-05	0.000314	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.28e-05	0.000313	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.25e-05	0.000307	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.04e-05	0.000256	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.03e-05	0.000253	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.86e-06	0.000242	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	9.74e-06	0.000239	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.6e-06	0.000235	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.1e-06	0.000223	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	8.89e-06	0.000218	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	8.7e-06	0.000213	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	8.32e-06	0.000204	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—ALB—chronic obstructive pulmonary disease	8.22e-06	0.000201	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.19e-06	0.000201	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	7.86e-06	0.000193	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.83e-06	0.000167	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.74e-06	0.000165	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.28e-06	0.000154	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	6.19e-06	0.000152	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.95e-06	0.000146	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	5.92e-06	0.000145	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	4.05e-06	9.91e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.87e-06	9.48e-05	CbGpPWpGaD
